Gemmer Asset Management LLC Emergent Bio Solutions Inc. Transaction History

Gemmer Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$27.42 - $43.63 $2,111 - $3,359	-77 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$36.48 - $52.22 $364 - $522	10 Added 14.93%	77 $3,000
Q3 2021 Oct 19, 2021	SELL	$50.07 - $66.05 $2,954 - $3,896	-59 Reduced 46.83%	67 $3,000
Q2 2021 Jul 23, 2021	BUY	$56.61 - $80.46 $3,339 - $4,747	59 Added 88.06%	126 $8,000
Q3 2018 Oct 12, 2018	SELL	$52.05 - $66.51 $1,197 - $1,529	-23 Reduced 25.56%	67 $4,000
Q3 2017 Oct 12, 2017	BUY	$34.14 - $40.45 $3,072 - $3,640	90	90 $4,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.